Biotech Connection Singapore
  • Home
  • About Us
    • About BCS
    • Executive Committee
    • Advisors
    • Alumni
  • Events
    • Past Events
    • Biotech Writing Competition
  • Consulting
    • Consulting
    • Singapore Life Science Case Competition
    • BCS Report –the Singapore Biotech Landscape
  • Communications
    • Academics to Industry
    • Career Series
    • COVID-19
    • Investment
    • Legal
    • Interviews
    • Emerging Industry Trends
    • Industry Practices
    • Research Methods
  • Contact
    • Jobs
    • Videos

Past Communications

Past Communications

Experimental Dengue Vaccine Protects all Recipients in Human Trials

An experimental dengue vaccine, TV003 that was developed by Dr. Whitehead and his colleagues at NIAID’s Laboratory of Infectious Diseases along with scientists from the U.S. Food and Drug Administration Center for Biologics Evaluation and Research protected 100% of the vaccine recipients in a clinical trial. Volunteers in this trial Read more…

By Biotech Connection Singapore, 8 yearsApril 1, 2016 ago

Posts navigation

Previous 1 2 3
For queries about Biotech Connection Singapore, its consulting service and articles, please email:info@biotechconnection-sg.org

Logo - Colour

Copyright© 2020, Biotech Connection Singapore. All Rights Reserved
  • Home
  • People
  • Events
  • Communications
  • Consulting
  • Contact
  • Home
Hestia | Developed by ThemeIsle